Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
Title:
Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts
Author:
Sharpe, Benjamin P. Hayden, Annette Manousopoulou, Antigoni Cowie, Andrew Walker, Robert C. Harrington, Jack Izadi, Fereshteh Breininger, Stella P. Gibson, Jane Pickering, Oliver Jaynes, Eleanor Kyle, Ewan Saunders, John H. Parsons, Simon L. Ritchie, Alison A. Clarke, Philip A. Collier, Pamela Mongan, Nigel P. Bates, David O. Yacqub-Usman, Kiren Garbis, Spiros D. Walters, Zoƫ Rose-Zerilli, Matthew Grabowska, Anna M. Underwood, Timothy J.